References
- FerlayJParkinDMSteliarova-FoucherEEstimates of cancer incidence and mortality in Europe in 2008Eur J Cancer201046476578120116997
- AhmedFYWiltshawEA’HernRPNatural history and prognosis of untreated stage I epithelial ovarian carcinomaJ Clin Oncol19961411296829758918494
- BinderPSPratJMutchDGThe future role of molecular staging in gynecologic cancerInt J Gynaecol Obstet2015131Suppl 2S127S13126433669
- YoungRCDeckerDGWhartonJTStaging laparotomy in early ovarian cancerJAMA198325022307230766358558
- PowlessCAAlettiGDBakkum-GamezJNClibyWARisk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical stagingGynecol Oncol2011122353654021636114
- Prat; JFIGO Committee on Gynecologic OncologyStaging classification for cancer of the ovary, fallopian tube, and peritoneumInt J Gynaecol Obstet201412411524219974
- HarrellFEJrRegression Modeling Strategies: with Applications to Linear Models, Logistic and Ordinal Regression, and Survival Analysis2nd edNew YorkSpringer2015
- ElattarABryantAWinter-RoachBAHatemMNaikROptimal primary surgical treatment for advanced epithelial ovarian cancer [review]Cochrane Database Syst Rev20118CD007565
- RosendahlMHøgdallCKMosgaardBJRestaging and Survival Analysis of 4036 Ovarian Cancer Patients According to the 2013 FIGO Classification for Ovarian, Fallopian Tube, and Primary Peritoneal CancerInt J Gynecol Cancer201626468068726937751
- SuhDHKimTHKimJWImprovements to the FIGO staging for ovarian cancer: reconsideration of lymphatic spread and intraoperative tumor ruptureJ Gynecol Oncol201324435235824167671
- PaikESLeeYYLeeEJSurvival analysis of revised 2013 FIGO staging classification of epithelial ovarian cancer and comparison with previous FIGO staging classificationObstet Gynecol Sci201558212413425798426
- ZeppernickFMeinhold-HeerleinIThe new FIGO staging system for ovarian, fallopian tube, and primary peritoneal cancerArch Gynecol Obstet2014290583984225082067
- WebberCGospodarowiczMSobinLHImproving the TNM classification: findings from a 10-year continuous literature reviewInt J Cancer2014135237137824921087
- MaringeCWaltersSButlerJICBP Module 1 Working GroupStage at diagnosis and ovarian cancer survival: evidence from the International Cancer Benchmarking PartnershipGynecolo Oncol201212717582
- AtasevenBHarterPGrimmCThe revised 2014 FIGO staging system for epithelial ovarian cancer: Is a subclassification into FIGO stage IVA and IVB justified?Gynecol Oncol2016142224324727208538
- TrimbosJBVergoteIBolisGEORTC-ACTION collaboratorsEuropean Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trialJ Natl Cancer Inst200395211312512529344
- TimmersPJZwindermanAHCoensCVergoteITrimbosJBUnderstanding the problem of inadequately staging early ovarian cancerEur J Cancer201046588088420074933
- KleppeMvan der AaMAVan GorpTSlangenBFKruitwagenRFThe impact of lymph node dissection and adjuvant chemotherapy on survival: A nationwide cohort study of patients with clinical early-stage ovarian cancerEur J Cancer201666839027536891
- ColomboNGuthrieDChiariSInternational Collaborative Ovarian Neoplasm (ICON) collaboratorsInternational Collaborative Ovarian Neoplasm trial 1: a randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancerJ Natl Cancer Inst200395212513212529345
- TrimbosBTimmersPPecorelliSSurgical staging and treatment of early ovarian cancer: long-term analysis from a randomized trialJ Natl Cancer Inst20101021398298720445161
- CollinsonFQianWFossatiROptimal treatment of early-stage ovarian cancerAnn Oncol20142561165117124631948
- International Collaborative Ovarian Neoplasm GroupPaclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trialLancet2002360933250551512241653
- BellJBradyMFYoungRCRandomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group studyGynecol Oncol2006102343243916860852
- VergoteIde BrabanterJFylesAPrognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinomaLancet2001357925117618211213094
- Bakkum-GamezJNRichardsonDLSeamonLGInfluence of intraoperative capsule rupture on outcomes in stage I epithelial ovarian cancerObstet Gynecol20091131111719104354
- SeidmanJDYemelyanovaAVKhedmatiFPrognostic factors for stage I ovarian carcinomaInt J Gynecol Pathol20102911719952945
- ChanJKTianCMonkBJPrognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group studyCancer2008112102202221018348296
- ObermairAFullerALopez-VarelaEA new prognostic model for FIGO stage 1 epithelial ovarian cancerGynecol Oncol2007104360761117092548
- KimHSAhnJHChungHHImpact of intraoperative rupture of the ovarian capsule on prognosis in patients with early-stage epithelial ovarian cancer: a meta-analysisEur J Surg Oncol201339327928923273873